GINKGO BIOWORKS HOLDINGS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements of $7.71 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements · last filed 2024-02-29
- GINKGO BIOWORKS HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, settlements for fiscal 2023 was $7.71M, a 25.92% decline from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, settlements for fiscal 2022 was $10.40M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements 12 month |
|---|---|
| 2023-12-31 | $7.71M 10-K · filed 2024-02-29 |
| 2022-12-31 | $10.40M 10-K · filed 2024-02-29 |